Myomo, Inc.
MYO NYSEΒ· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Last close Β· Oct 26, 2026
$1.20
KIRA Β· Stoqlyβs AI analyst, in plain words
- Myomo, Inc. had $40.9M of revenue in fiscal 2025, up 25.7% on the year before. Over five years, revenue changed +40.1% a year on average.
- Its operating margin was β35.2%, down 16.1Β pts: of every 100 in sales, about β35 is left after running the business.
- Myomo, Inc. lost $15.6M in fiscal 2025.
- Free cash flow was β$16.3M in fiscal 2025, β39.7% of revenue.
- Myomo, Inc. has $7.2M more cash than debt.
Market cap
$51.2M
P/E
β
Revenue
$40.9M
Net income
β$15.6M
Free cash flow
β$16.3M
Operating margin
β35.2%
Myomo, Inc. in 30 seconds Β· fiscal 2025
Are sales growing?
+25.7%
Yes. Sales grew 25.7% last year.
Does it make a profit?
β38.1%
No. It lost money last year.
Does profit turn into cash?
β39.7%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 9
Weak. It passes 3 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Myomo, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 9, 2026
- Legal name
- MYOMO, INC.
- CIK
- 0001369290
Myomo, Inc. Β· MYO
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $13.9M | $15.6M | $19.2M | $32.6M | $40.9M |
| Revenue growth | 82.7% | 12.3% | 23.7% | 69.2% | 25.7% |
| Gross margin | 74.4% | 65.9% | 68.5% | 71.2% | 65.7% |
| Operating margin | β74.1% | β68.6% | β42.8% | β19.1% | β35.2% |
| Net income | β$10.4M | β$10.7M | β$8.1M | β$6.2M | β$15.6M |
| Net margin | β74.9% | β68.9% | β42.3% | β19.0% | β38.1% |
| Diluted EPS | β$1.89 | β$1.52 | β$0.28 | β$0.16 | β$0.37 |
| Cash | |||||
| Cash from operations | β$9.5M | β$10.2M | β$6.2M | β$3.3M | β$14.5M |
| Capital expenditure | $0.3M | $0.1M | $0.1M | $1.4M | $1.7M |
| Free cash flow | β$9.9M | β$10.3M | β$6.3M | β$4.7M | β$16.3M |
| FCF margin | β71.3% | β66.5% | β32.8% | β14.3% | β39.7% |
| Share count change | 75.1% | 20.9% | 318.3% | 28.0% | 10.8% |
| Debt and strength | |||||
| Cash and short-term investments | $15.5M | $5.3M | $8.9M | $24.9M | $18.4M |
| Debt incl. finance leases | β | β | β | $11.2M | $11.2M |
| Shareholders' equity | $15.4M | $6.4M | $9.0M | $24.7M | $11.4M |
| Current ratio | 4.5x | 2.6x | 2.5x | 3.2x | 3.3x |
| Returns and quality | |||||
| Return on capital | β | β | β | β44.3% | β268.8% |
| Return on equity | β76.9% | β98.5% | β106.2% | β36.7% | β86.2% |
| Return on tangible equity | β71.5% | β168.6% | β90.6% | β25.0% | β136.6% |
| Piotroski F-score | 4 | 2 | 3 | 4 | 3 |
| Altman Z'' | β7.8 | β30.2 | β20.1 | β4.0 | β8.8 |
Insiders bought, 12 months
$0.4M
4 insiders
Insiders sold, 12 months
$0.1M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Myomo, Inc. Β· MYO
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.20 a share, the company is worth $51.2M.
Source: SEC EDGAR XBRL filings (CIK 0001369290). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
